Jeffrey Leflein

Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial

Amy S. Paller, Eric L. Simpson, Elaine C. Siegfried et al. · The Lancet · 2022 · 242 citations · Full text

Asthma, Uncontrolled Atopic Dermatitis, Atopic Dermatitis +4

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 168 citations · Full text

Asthma, Severe Eosinophilic Asthma, Allergy +10

Nebulized Budesonide Inhalation Suspension Compared With Cromolyn Sodium Nebulizer Solution for Asthma in Young Children: Results of a Randomized Outcomes Trial

Jeffrey Leflein, Stanley J. Szefler, Kevin R. Murphy et al. · PEDIATRICS · 2002 · 76 citations

Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma

James E. Fish, Jill P. Karpel, Timothy Craig et al. · Journal of Allergy and Clinical Immunology · 2000 · 72 citations · Full text

Asthma, Severe Persistent Asthma, Health-related Quality +5

Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials

Marcus Maurer, Luís Felipe Ensina, Ana M. Giménez‐Arnau et al. · The Lancet · 2023 · 58 citations

Rheumatology, Clinical Trials, Clinical Dermatology +5